• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[生长抑素类似物在神经内分泌肠道肿瘤治疗中的应用]

[Somatostatin analogue in the treatment of neuroendocrine gut tumors].

作者信息

Ben Yosef R, Glaser B, Catane R

机构信息

Dept. of Oncology, Hadassah Medical Center, Jerusalem.

出版信息

Harefuah. 1990 Jul;119(1-2):15-8.

PMID:2172125
Abstract

Somatostatin is a short-acting natural peptide secreted by specialized cells in the GI tract, the central and peripheral nervous systems, and a variety of other tissues. Its many actions include suppression of the secretion of GH, TSH, GI hormones, and inhibition of GI exocrine secretion. A long-acting analogue developed by Sandoz (Sandostatin, SMS 201-995) has been used to treat acromegaly and neuroendocrine tumors. We report our experience with it in carcinoid tumors (4 cases), glucagonomas (2), gastrinoma (1), VIPoma (1) and nonfunctioning islet cell tumor (1). It was given by continuous subcutaneous infusion, using a small portable pump, in doses ranging from 300 to 1500 mcg/day, without significant side-effects. 7 of the 9 patients had complete relief of symptoms, and tumoral hormone secretion decreased in 4 of the 5 in whom it was measurable, but there was no evidence of tumor regression. SMS 201-995 is useful for the symptomatic treatment of patients with neuroendocrine gut tumors.

摘要

生长抑素是一种短效天然肽,由胃肠道、中枢和外周神经系统以及多种其他组织中的特化细胞分泌。它的多种作用包括抑制生长激素、促甲状腺激素、胃肠激素的分泌,以及抑制胃肠外分泌。山德士公司研发的一种长效类似物(善宁,SMS 201-995)已被用于治疗肢端肥大症和神经内分泌肿瘤。我们报告了其在类癌肿瘤(4例)、胰高血糖素瘤(2例)、胃泌素瘤(1例)、血管活性肠肽瘤(1例)和无功能性胰岛细胞瘤(1例)中的应用经验。使用小型便携式泵通过皮下持续输注给药,剂量为每天300至1500微克,无明显副作用。9例患者中有7例症状完全缓解,5例可测量肿瘤激素分泌的患者中有4例肿瘤激素分泌减少,但没有肿瘤缩小的证据。SMS 201-995对神经内分泌肠道肿瘤患者的症状性治疗有用。

相似文献

1
[Somatostatin analogue in the treatment of neuroendocrine gut tumors].[生长抑素类似物在神经内分泌肠道肿瘤治疗中的应用]
Harefuah. 1990 Jul;119(1-2):15-8.
2
[Treatment of gastrointestinal neuroendocrine tumors with the somatostatin analog octreotide (Sandostatin)].用生长抑素类似物奥曲肽(善宁)治疗胃肠道神经内分泌肿瘤
Z Gastroenterol. 1988 Oct;26(10):665-75.
3
Use of long-acting somatostatin analog SMS 201-995 in patients with pancreatic islet cell tumors.长效生长抑素类似物SMS 201-995在胰岛细胞瘤患者中的应用。
Dig Dis Sci. 1989 Mar;34(3 Suppl):28S-39S. doi: 10.1007/BF01536043.
4
Clinical evaluation of SMS 201-995. Long-term treatment in gut neuroendocrine tumours, efficacy of oral administration, and possible use in non-tumoural inappropriate TSH hypersecretion.SMS 201-995的临床评估。肠道神经内分泌肿瘤的长期治疗、口服给药的疗效以及在非肿瘤性不适当促甲状腺激素分泌过多症中的可能应用。
Acta Endocrinol Suppl (Copenh). 1987;286:26-36.
5
Clinical efficacy of octreotide in the treatment of metastatic neuroendocrine tumors. A study by the Italian Trials in Medical Oncology Group.奥曲肽治疗转移性神经内分泌肿瘤的临床疗效。意大利医学肿瘤学试验组的一项研究。
Cancer. 1996 Jan 15;77(2):402-8. doi: 10.1002/(SICI)1097-0142(19960115)77:2<402::AID-CNCR25>3.0.CO;2-4.
6
Detection of somatostatin receptors in surgical and percutaneous needle biopsy samples of carcinoids and islet cell carcinomas.在类癌和胰岛细胞癌的手术及经皮针吸活检样本中检测生长抑素受体。
Cancer Res. 1990 Sep 15;50(18):5969-77.
7
Management of gastroenteropancreatic endocrine tumors: the place of somatostatin analogues.胃肠胰内分泌肿瘤的管理:生长抑素类似物的地位
Digestion. 1994;55 Suppl 3:107-13. doi: 10.1159/000201211.
8
Suppression of primary and secondary peptides with somatostatin analog in the therapy of functional endocrine tumors.生长抑素类似物对原发性和继发性肽的抑制作用在功能性内分泌肿瘤治疗中的应用
Surg Gynecol Obstet. 1988 Dec;167(6):453-62.
9
[Therapy of endocrine gastrointestinal-pancreatic tumors with somatostatin analog octreotide].生长抑素类似物奥曲肽治疗内分泌性胃肠胰肿瘤
Dtsch Med Wochenschr. 1992 Jul 3;117(27):1067-71. doi: 10.1055/s-2008-1062412.
10
Vipoma, glucagonoma and the role of Sandostatin.血管活性肠肽瘤、胰高血糖素瘤与善得定的作用
NATNEWS. 1989 Jul;26(7):15.